Clinical Trial 12089

Raleigh, NC 27612

Study Summary:

FDA-approved GRALISE™ (once daily) Phase IV Study We understand, PAIN and SHINGLES can leave you feeling like a pincushion. Check out this new study! GRALISE™ was recently approved for the FDA for PHN in the U.S.

Qualified Participants Must:

• Be 18 years of age or older
• Currently be experiencing postherpetic neuralgia (PHN)

Qualified Participants May Receive:

9 weeks of medication free of cost. All study-related visits and procedures will also be provided at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.